Displaying drugs 7826 - 7850 of 8071 in total
1,3-diphenylurea
Experimental
(R)-warfarin
Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in producing an anticoagulant response.
Experimental
1,3-bis-([[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-ethyl]-amino-carbonyloxy)-2-amino-propane
Experimental
Matched Iupac: … piperazin-1-yl]propyl}-3-nitro-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzene-1-carboximidic acid …
Alsactide
Experimental
Matched Iupac: … aminopropanamido)-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]butanoic acid …
Hydroxyaminovaline
Experimental
2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
Experimental
Propatyl nitrate
Experimental
Investigational
Methylpropylpropanediol dinitrate
Experimental
Aminoquinuride
Experimental
4-Iodobenzo[B]Thiophene-2-Carboxamidine
Experimental
Estradiol sulfamate
Investigational
Simendan
Simendan is under investigation in clinical trial NCT00527059 (Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure).
Investigational
Hypericin
Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.
Investigational
N-Cyclohexyl-N'-(4-Iodophenyl)Urea
Experimental
R,S-Warfarin alcohol
Experimental
Zk-806450
Experimental
Displaying drugs 7826 - 7850 of 8071 in total